Melbourne, Sep 4, 2015 - (ABN Newswire) - Rhinomed Ltd (ASX:RNO) has been building its international presence and connections amongst the international investment and pharmaceutical community this year. In March, Michael Johnson was the keynote ‘Rising Star’ presentation at the Master Investor Show in London. The Show was attended by 4700 investors covering private investors, brokers, funds and analysts.
Rhinomed was invited to present at the conference by Jim Mellon, one of the UK’s most successful investors. It was an excellent opportunity for Rhinomed to showcase its technology to an international audience.
Rhinomed’s presentation titled ‘Changing the way the world breathes’ can be viewed on Youtube at: http://www.youtube.com/watch?v=hNXqk-OiAbY
Rhinomed CEO, Michael Johnson, was joined on the stage by Rhinomed shareholder and brand ambassador, Sir Steve Redgrave, CBE - the 5 time consecutive Olympic gold medallist, who is recognised as one of the greatest Olympians of all time.
Sir Steve brings an incredible depth of experience in the importance of breathing in sport but also recovery for athletes. He also provided some insights into the difficulties of obtaining quality sleep when competing at the highest level.
BIO2015 in June
Rhinomed presented and exhibited at BIO2015 in Philadelphia in June - as part of the Victorian Government delegation. The conference is attended by over 15,000 industry professionals from around the globe and Rhinomed held back-back meetings across the program to discuss potential partnering and distribution opportunities.
Interbike 2015
Turbine will be exhibiting at Interbike 2015 in September this year. Interbike is the one-stop show to connect with all aspects of the entire bicycle industry, including products and latest trends. It includes both outdoor demonstration days and an indoor exhibition.
Turbine will be exhibiting and meeting with potential distributors and retailers from across the globe. “Interbike was incredibly successful at launching Turbine on the international stage last year and we are looking forward to building on this in 2015,” Michael Johnson said.
To view the full newsletter and all updates, please visit: http://media.abnnewswire.net/media/en/docs/ASX-RNO-429283.pdf
About: Rhinomed Ltd
Rhinomed Limited (ASX:RNO) is a medical technology firm that focuses on nasal, respiratory and breathing management technologies. The company is monetising its technology portfolio in the Sport and recreation market, Sleep, Wellbeing and Drug delivery markets.
Rhinomed’s technology is designed to radically improve the way you breathe sleep, maintain your health and take medication.
The first product brought to market is the Turbine(TM). A radical nasal technology that improves airflow by an average of 38%, the Turbine(TM) is an internal nasal dilator that has since it’s launch in January 2014 in Australia, grown to be widely adopted by leading cyclists and triathletes globally.
Now shipped to over 36 countries and with a growing global distribution base, the Turbine(TM) is providing all those undertaking aerobic activities with an opportunity to breathe better, perform better and get more enjoyment from their sport and exercise.
Help employers find you! Check out all the jobs and post your resume.
